title: Helicobacter pylori eradication therapy: A review of current trends.
abstract: Helicobacter pylori has been implicated in the formation of chronic gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma and gastric cancer. Eradication of H. Pylori has been recommended as treatment and prevention for these complications. This review is based on a search of Medline, the Cochrane Database of Systemic Reviews, and citation lists of relevant publications. Subject heading and key words used include H. Pylori, current treatment and emerging therapy. Only articles in English were included. There has been a substantial decline in the H. pylori eradication rates over the years, despite the use of proton pump inhibitor and bismuth salts for triple and quadruple therapies respectively. The reasons for eradication failure are diverse, among them, antibiotic resistance is an important factor in the treatment failure. Primary resistance to clarithromycin or metronidazole significantly affects the efficacy of eradication therapy. This has led to the introduction of second line, third line "rescue," and sequential therapies for resistant cases. Subsequently, new antibiotic combinations with proton-pump inhibitors and bismuth salts are being studied in the last decade, to find out the antibiotics that are capable of increasing the eradication rates. Some of these antibiotics include Levofloxacin, Doxycycline, Rifaximin, Rifampicin, Furazolidone based therapies. Studies are ongoing to determine the efficacy of Lactoferrin based therapy.
authors: Department of Medicine, Gastroenterology Unit, University of Ilorin Teaching Hospital, Ilorin, Nigeria.
authors: A B
authors: AB
authors: Olokoba
authors: O A
authors: OA
authors: Obateru
authors: M O
authors: MO
authors: Bojuwoye
keywords: Bismuth salts; Helicobacter pylori; emerging therapies; proton-pump inhibitor
references: Dig Liver Dis. 2003 Aug;35(8):523-8
references: 14567454
references: Aliment Pharmacol Ther. 2002 Jul;16(7):1261-7
references: 12144575
references: Helicobacter. 2003 Apr;8(2):90-4
references: 12662375
references: Gut. 2010 Aug;59(8):1143-53
references: 20525969
references: World J Gastroenterol. 2006 Apr 21;12(15):2313-9
references: 16688818
references: Helicobacter. 2005 Oct;10(5):363-72
references: 16181345
references: Scand J Gastroenterol Suppl. 1989;169:70-80
references: 2694347
references: Dig Liver Dis. 2007 Sep;39(9):806-10
references: 17644057
references: World J Gastroenterol. 1998 Oct;4(5):385-387
references: 11819327
references: Aliment Pharmacol Ther. 2000 Oct;14(10):1319-28
references: 11012477
references: Adv Exp Med Biol. 2008;606:163-94
references: 18183929
references: Aliment Pharmacol Ther. 2001 Jan;15(1):143
references: 11136288
references: Helicobacter. 2007 Oct;12 Suppl 1:31-7
references: 17727458
references: Eur J Clin Microbiol Infect Dis. 2000 Jul;19(7):538-41
references: 10968325
references: Aliment Pharmacol Ther. 2003 Mar 1;17(5):719-26
references: 12641522
references: Aliment Pharmacol Ther. 2004 Apr 1;19(7):789-95
references: 15043520
references: J Clin Gastroenterol. 2003 May-Jun;36(5):396-8
references: 12702979
references: Clin Infect Dis. 2002 Aug 1;35(3):240-5
references: 12115088
references: Aliment Pharmacol Ther. 2002 Mar;16 Suppl 1:24-30
references: 11849124
references: Nat Clin Pract Gastroenterol Hepatol. 2008 Jun;5(6):321-31
references: 18446147
references: Aliment Pharmacol Ther. 2000 Mar;14(3):311-6
references: 10735924
references: Helicobacter. 2006 Feb;11(1):52-5
references: 16423090
references: Am J Gastroenterol. 2000 Dec;95(12):3393-8
references: 11151867
references: Dig Dis Sci. 2000 Jan;45(1):68-76
references: 10695616
references: Antimicrob Agents Chemother. 1999 Jun;43(6):1497-9
references: 10348780
references: N Engl J Med. 2010 Apr 29;362(17):1597-604
references: 20427808
references: BMC Gastroenterol. 2001;1:7
references: 11545677
references: Ann Intern Med. 2006 Jan 17;144(2):140-1
references: 16418415
references: Aliment Pharmacol Ther. 2005 Jul 1;22(1):45-9
references: 15963079
references: Physiol Rev. 2010 Jul;90(3):831-58
references: 20664074
references: Drugs. 1994 Jun;47(6):983-1009
references: 7521834
references: Best Pract Res Clin Gastroenterol. 2007;21(2):335-46
references: 17382281
references: Antimicrob Agents Chemother. 2001 Jan;45(1):306-8
references: 11120984
references: Aliment Pharmacol Ther. 2002 Feb;16(2):167-80
references: 11860399
references: Helicobacter. 2002 Aug;7(4):225-31
references: 12165029
references: J Korean Med Sci. 2011 Jun;26(6):785-90
references: 21655065
references: Gut. 1997 Jul;41(1):8-13
references: 9274464